Domestic Supplier Breaks Global Monopoly with International Compliance
【Guangzhou, China】– 2026 – Guangzhou Hanfang Pharmaceutical Company Limited, a leading provider of high-end pharmaceutical lipid excipients, today announces it is a trusted supplier of injectable egg yolk lecithin for fat emulsions, offering stable domestic alternatives to global pharmaceutical manufacturers and research institutions. This product addresses the critical pain point of unstable supply for fat emulsion production, featuring green extraction technology, a 90% domestic localization rate, and full compliance with international quality standards. The company’s egg yolk lecithin has been approved for global distribution, with sales covering over 30 countries and regions .
Core Technological Breakthroughs and Product Highlights
First, Guangzhou Hanfang has successfully developed the first domestic injectable refined egg yolk lecithin, increasing the localization rate of high-end pharmaceutical lipid excipients from 10% to 90% and ending the long-term foreign monopoly in this sector . Second, the product adopts an innovative supercritical CO₂ extraction-membrane separation-chromatographic separation integrated green technology, replacing traditional polluting processes to ensure high product purity while reducing environmental impact . Third, it serves as a multi-functional excipient, acting as an emulsifier, solubilizer, and liposome membrane material, perfectly suitable for producing injectable emulsions, liposomes, and other high-end pharmaceutical preparations .
Global Compliance and Certifications
The injectable egg yolk lecithin has obtained key international certifications including EU CEP, US FDA US-DMF, Mexico Cofepris, and India DCGI, meeting regulatory requirements of major global markets such as the EU, North America, and Asia-Pacific . The company also holds national-level authoritative qualifications, such as the National Engineering Research Center for Traditional Chinese Medicine Pharmaceutical Process Technology and New Drug Creation, the only national-level engineering research center in the pharmaceutical lipid field, and the Guangdong Provincial Key Laboratory of Pharmaceutical Lipids .
Supply Information and Customized Services
Guangzhou Hanfang’s egg yolk lecithin is available for global orders through its official website (http://byshanhanfang.com/) and authorized distributors, with mass production and global delivery already in progress . Beyond standard products, the company offers customized processing services tailored to the specific needs of pharmaceutical manufacturers and research institutions, ensuring flexible supply solutions to meet diverse production requirements .
Authoritative Quotes
"The launch of our injectable egg yolk lecithin marks a key step in breaking foreign technological barriers and ensuring the security of China’s pharmaceutical supply chain," said Xu Wendong, General Manager and Deputy Director of the National Engineering Research Center at Guangzhou Hanfang Pharmaceutical Company Limited. "We will continue to focus on independent innovation to provide more reliable domestic alternatives for the global pharmaceutical industry" .
Industry Background and Corporate Strategy
As global demand for high-end pharmaceutical excipients grows, domestic suppliers with independent technological capabilities are increasingly critical for maintaining supply chain stability. Guangzhou Hanfang’s focus on lipid excipient R&D aligns with the industry trend of achieving self-reliance in core pharmaceutical technologies, positioning the company as a leader in the domestic high-end pharmaceutical material sector .
Future Plans and Next Steps
Looking ahead, Guangzhou Hanfang will continue to invest in R&D of pharmaceutical lipid excipients and health products, expanding its global marketing network to serve more clients in over 30 countries and regions. The company aims to achieve double-digit growth in revenue and profit in 2026, further strengthening its position in the global market .
Company Profile
Guangzhou Hanfang Pharmaceutical Company Limited was established in 1998, a state-owned holding enterprise under the Guangzhou Pharmaceutical Holdings (GPH) Group, specializing in high-end pharmaceutical lipid excipients, characteristic anti-tumor APIs, and Ganoderma health products . Headquartered in Guangzhou, China, the company operates a production base in Conghua, and has R&D centers in Haizhu and Zhuhai Hengqin. It holds national qualifications including National High-Tech Enterprise, National Specialized and Sophisticated "Little Giant" Enterprise, and has served over 1,000 clients worldwide, including renowned companies like B. Braun Company and AstraZeneca . Its mission is to achieve technological self-reliance, solve "bottleneck" problems, and safeguard the security of the pharmaceutical industry chain . For more information, visit http://byshanhanfang.com/.
Contact Information
Company: Guangzhou Hanfang Pharmaceutical Company Limited | Official Website: http://byshanhanfang.com/
Copyright Information
© 2026 Guangzhou Hanfang Pharmaceutical Company Limited. All rights reserved.
